Jeppson财富管理公司投资35,000美元 投资给生物制药公司Rezolute Inc. 分析师将它评为“Moderate Buy”。 Jeppson Wealth Management invests $35,000 in biopharmaceutical firm Rezolute, Inc., with analysts rating it a "Moderate Buy."

Jeppson财富管理有限责任公司最近投资35 000美元给Rezulute公司(NASDAQ:RZLT),该公司是一家生物制药公司,开发新陈代谢疾病的治疗方法。 Jeppson Wealth Management LLC recently invested $35,000 in Rezolute, Inc. (NASDAQ:RZLT), a biopharmaceutical company developing treatments for metabolic diseases. Rezolute的铅产品RZ358正在第2b阶段试验,以治疗罕见的儿科障碍。 Rezolute's lead product, RZ358, is in Phase 2b trials for a rare pediatric disorder. 该公司的市场上限为3.72亿美元,分析师将其评为“机动购买”,价格目标为11.83美元。 The company has a market cap of $372 million and analysts rate it as a "Moderate Buy" with a price target of $11.83. 内幕人士也增加了他们在公司中的股份。 Insiders have also increased their stakes in the company.